Ignite Creation Date:
2024-05-06 @ 3:06 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04529044
Status:
UNKNOWN
Last Update Posted:
2022-07-11
First Post:
2020-08-24
Brief Title:
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
Sponsor:
OHSU Knight Cancer Institute
Organization:
OHSU Knight Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Anatomic Stage IV Breast Cancer AJCC v8 |
| Metastatic Breast Carcinoma |
| Prognostic Stage IV Breast Cancer AJCC v8 |
| Recurrent Breast Carcinoma |
Keywords: